Pediatric Academic
Societies'
Annual Meeting

        HOME                                                                                                                                         SITE MAP  

   
 

Sponsoring Organizations
Click on the links below to visit individual websites
American Pediatric Society
Society for Pediatric Research
Ambulatory Pediatric Association

Alliance Organizations

Program Information

Program Committee & Contacts

Abstracts

Awards

Registration & Housing

Exhibits

Support and Partnerships

Future Meetings

Past Meetings

Pediatric Related Links

Contact Information
Mail Address:
Suite B-7
3400 Research Forest Drive
The Woodlands, TX  77381 USA
Telephone:  281-419-0052
Facsimile:  281-419-0082

MEETING PROGRAM BY SUBSPECIALTY/TRACK


Return to Track Selection

Go to Day-by-Day Schedule Go to Alliance Programs Go to 
PAS Meeting Home 

GASTROENTEROLOGY AND NUTRITION

Saturday, May 4, 2002

8:30am-11:30am
Special Interest Group
4008 Nutrition
We are developing a "Teacher's Guide to Clinical Pediatric Nutrition". Our objectives are to:

1. provide the essential vocabulary and knowledge of pediatric nutrition and
2. enable use of that vocabulary and knowledge in clinical settings.

We have already prepared a 42 page monograph, "Pediatric Nutrition Notes" written for 3rd year medical students. These Notes accomplish our first objective. In the SIG session in Baltimore, Saturday morning of May 4th, we will develop the matrix for the second part of the project -- "A Case Book of Clinical Pediatric Nutrition." The Case Book will enable pediatric residents to apply basic principles of nutrition in clinical practice -- our second objective. Those interested in participating can obtain a full prospectus for the project by contacting one of the organizers:

Robert Karp - Rkarp@downstate.edu
Sandra Hassink - shassink@NEMOURS.ORG
Steven Bachrach - sbachrac@NEMOURS.ORG
Elizabeth Shepard - Shepardwe@aol.com
Chair: Sandy Hassink, Shassink@nemours.org

1:00pm-3:00pm
Poster Symposium
4182 Historical Perspectives
Chairs: Thor Willy Hansen and James Kendig

3:15pm-5:15pm
Topic Symposium
4200 Cloning and Embryonic Stem Cells
Chair: Judith Hall, University of British Columbia, Vancouver, Canada

There is enormous public interest in cloning and embryonic stem cells. This symposium will update the pediatric community on recent developments and raises a variety of policy and ethical issues.

Overview
Judith G. Hall, University of British Columbia, Vancouver, Canada
Imprinting and Reprogramming
Arthur L. Beaudet, Baylor College of Medicine, Houston, TX
Cloning
Brigid Hogan, Vanderbilt University Medical Center and the Howard Hughes Medical Institute, Nashville, TN
Embryonic Stem Cells
Janet Rossant, Samuel Lunenfeld Research Institute, Mount Sinai Hospital ON, Canada

3:15pm-5:15pm
Poster Symposium
4256 Neonatal and Fetal Nutrition and Metabolism I
Chairs: Dennis Bier and Patti Thureen

5:15pm-7:15pm
Poster Session I (Author Attended)
and Opening Reception
Endocrinology

7:15pm-9:30pm
Alliance Club
4500A Perinatal Nutrition and Metabolism Club
Long-Term Developmental Consequences of Perinatal Malnutrition
Janina Galler, Boston University School of Medicine, Boston, MA

Supported by an educational grant from the Ross Pediatrics

Sunday, May 5, 2002

8:00am-10:00am
Platform Session
5054 Neonatal and Fetal Nutrition and Metabolism II
Chairs: Michael K. Georgieff and Satish C. Kalhan

8:00am-11:00am
Mini Course
5090 Adolescent Medicine - Part II—Eating Disorders
Chair: Donald E. Greydanus, Michigan State University, Kalamazoo, MI
This presentation will present an overview of the research on the diagnosis, assessment, and treatment (therapy: including psychological and pharmacological; settings: inpatient, day treatment, and outpatient) of adolescents with eating disorders. A brief comparison of the diagnostic criteria used by the American Psychiatric Association and the World Health Organization will be presented and discussed regarding the relevance to research design and diagnosis. Special issues (such as research design, subject selection, research settings, geographical location, definitions, terminology, race and culture, managed care, and reimbursement) and their impact on our current knowledge base and on treatment choices will be addressed. Recommendations for future directions in assessment, treatment, and research will be offered.

Overview
Donald E. Greydanus, Michigan State University College of Human Medicine, Kalamazoo, MI
Diagnostic Criteria: American Psychiatric Association, World Health Organization, Implications for Diagnosing Adolescents
Helen D. Pratt, Michigan State University, Center for Medical Studies, Kalamazoo, MI
Special Issues: Subject Selection: Gender, Race, Ethnicity, Sexual Orientation
Helen D. Pratt, Michigan State University, Center for Medical Studies, Kalamazoo, MI
Research Design: Research/Treatment Settings, Inpatient, Day Treatment, Outpatient, Hospital, Clinic, Community, Geographical Location, Definitions, Disorders, Recovery
Helen D. Pratt, Michigan State University, Center for Medical Studies, Kalamazoo, MI
Break
Treatment Interventions: Psychological, Psycho-pharmacologic
Helen D. Pratt, Michigan State University, Center for Medical Studies, Kalamazoo, MI
Treatment Outcomes
Helen D. Pratt, Michigan State University, Center for Medical Studies, Kalamazoo, MI
Recommendations for Future Research
Helen D. Pratt, Michigan State University, Center for Medical Studies, Kalamazoo, MI
Discussion

11:45am-1:45pm
Poster Session II (Author Attended)
Neonatology

1:45pm-2:30pm
State of the Art Plenary
5590 Children as Victims of Bioterrorism: Protecting the Fragile Host
Chairs: Phyllis Dennery, Stanford University School of Medicine, Palo Alto, CA and Tina Lee Cheng, Johns Hopkins University School of Medicine, Baltimore, MD
With the recent world events and new threats of biowarfare, what should pediatricians know? Due to their size and physiology, children are at higher risk of injury from bioterrorism. This session will address the biology, clinical manifestations, and possible preventive strategies for likely biowarfare agents. The unique vulnerability of the child will be addressed.

Overview
Phyllis A. Dennery, Stanford University School of Medicine, Palo Alto, CA
Children as Victims of Bioterrorism: Protecting the Fragile Host
Ralph D. Feigin, Baylor College of Medicine, Houston, TX
Discussion
2:00pm-4:00pm
State of the Art Plenary
5701 Children as Research Subjects: Ethical and Regulatory Issues
Chair: Myron Genel, Yale University School of Medicine, New Haven, CT

A number of highly publicized adverse events, including the death of two volunteers participating in non-therapeutic research, and the federal shutdown of research at many well-recognized academic institutions because of inadequate compliance with regulatory requirements have intensified scrutiny of the protection afforded to human subjects participating in research, including children. Furthermore a Maryland court has recently decreed that children cannot participate in research without the potential for direct benefit. As a consequence there has been increasing media attention and Congressional concern regarding the adequacy of institutional oversight and investigator attentiveness to established standards and regulations. In addition, new regulations issued under the Health Insurance Portability and Accountability Act of l996(HIPAA) threaten the capacity to conduct health services and outcomes research. These issues will be addressed in the 9th annual Public Policy Plenary Symposium in an interactive format intended to stimulate dialogue among the members of the panel and with the audience.

Overview
Myron Genel, Yale University School of Medicine, New Haven, CT
Overseeing Research in Children: New Concerns and New Regulations
Alan R. Fleischman, The New York Academy of Medicine, New York, NY
International Health Research: Where Bioethics, Politics and Economics Converge
Eric M. Meslin, Indiana University Center for Bioethics, Indianapolis, IN
Compliance: What You and Your Institution Need to Know (and Do)
Pearl O'Rourke, Partners HealthCare System, Inc., Boston, MA
HIPAA, Privacy & Confidentiality and Research In Children?
Brian Kamoie, The George Washington University, Washington, DC
Discussion

Sponsored jointly with the Public Policy Council of the APS, AMSPDC, SPR and the Public Policy Committee of the APA
Partially supported by an educational grant from Columbus Children's Hospital

2:30pm-4:00pm
State of the Art Plenary
5703 Insulin Resistance Syndromes
Chairs: Alan Rogol, Insmed Pharmaceuticals, Inc., Glen Allen, VA and Charlotte Boney, Rhode Island Hospital, Providence, RI
Insulin resistance is the underlying factor in many of the consequences of obesity in childhood and adolescence, including ovarian hyperandrogenism, hypertension, hyperlipidemia, and Type 2 diabetes. Obesity, dyslipidemia, and Type 2 diabetes are components of SyndromeX in adults, a serious public health issue. In addition, insulin has a role in the regulation of leptin, the major signal of adiposity to the brain. Dr. Arslanian will discuss insulin resistance in polycystic ovary disease and Type 2 diabetes. Dr. Freedman will review the cardiac risk factors related to insulin resistance, and Dr. Roemmich will discuss the insulin-leptin axis in obesity and puberty.

Insulin Resistance: It's Not for Adults Only
Silva A. Arslanian, Children's Hospital of Pittsburgh, Pittsburgh, PA
Clustering of Coronary Heart Disease Risk Factors in Obese Children
David Freedman, Division of Nutrition and Physical Activity, Centers for Disease Control, Atlanta, GA
The Insulin-Leptin Axis in Puberty
James Roemmich, School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY

Sponsored jointly with the Lawson Wilkins Pediatric Endocrine Society and the American Academy of Pediatrics

2:30pm-4:00pm
State of the Art Plenary
5704 Pediatric Research and the Human DNA Sequence: Approaching Defects of Host Defenses in the Genomic Era
Chairs: Jennifer M. Puck, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD and Stephen J. Chanock, National Cancer Institute, National Institutes of Health, Bethesda, MD
This session will provide a framework for understanding how genetics and genomics can accelerate progress in understanding defects in immunity and host defenses. Host defenses are used to demonstrate the general power of these technologies to elucidate pathogenetic mechanisms and predict disease susceptibility. This program will address classical and novel approaches to discovering genes underlying primary immunodeficiencies as well as characterization of modifier genes. A brief overview of the human genome, its structure, contents and relationship to genomes of other species will be presented in order to discuss current and future potential for understanding pediatric diseases and treatments. Emphasis will be placed on the continued prime importance of careful clinical observation, as well as the ethical and practical issues that genome science presents to society.

Finding a Multitude of Disease Genes for Primary Immune Disorders
Jennifer M. Puck, National Human Genome Research Institute/National Institutes of Health, Bethesda, MD
The Role of Vairation in the Human Genome: Single Nucleotide Polymorphisms and Disease Modifiers
Stephen J. Chanock, National Cancer Institute, National Institutes of Health, Bethesda, MD
Applications of Genomic Technology to Understanding Human Phenotypes
Aravinda Chakravarti, Johns Hopkins University School of Medicine, Baltimore, MD

Sponsored jointly with the Pediatric Infectious Diseases Society

4:15pm-6:15pm
Topic Symposium
5801 IUGR—Recent Advances
Chair: David Carlton, University of Wisconsin, Madison, WI

Intra-uterine growth restriction leads to various adaptive changes in blood flow and metabolism which leads to fetal survival in an adverse environment. This session will address these adaptive changes which occur in-utero and the long-term impact secondary to these changes in the adult IUGR progeny. Dr. Battaglia will present information related to blood flow and hepatic metabolism in the human fetus/infant, Dr. Devaskar and Dr. Hill will present work in animal models that sets the IUGR fetus towards developing diabetes as an adult. Dr. Devaskar will present changes in various organs, while Dr. Hill will focus on changes that occur in the beta-islets of the pancreas.

Clinical Studies of the Fetal Circulation and Placental Transport
Frederick C. Battaglia, University of Colorado School of Medicine, Denver, CO
Animal Studies - Adult Outcome of the IUGR Fetus
Sherin U. Devaskar, University of California, Los Angeles, CA
The Impact of IUGR on the Development and Postnatal Function of the Endocrine Pancreas
David Hill, University of Western Ontario, Canada

4:15pm-6:15pm
Platform Session
5911 Pediatric Nutrition and Metabolism
Chair: Michael R. Narkewicz

Monday, May 6, 2002

8:00am-10:00am
Poster Symposium
6050 Advances in Clinical Nutrition
Chairs: Michael R. Narkewicz and David K. Rassin

10:15am-12:15pm
Platform Session
6202 General Pediatrics II
Chairs: Thomas M. Ball and Mary Ottolini

12:30pm-2:30pm
Award
6400 March of Dimes Prize in Developmental Biology Lectures
Presented by the March of Dimes Birth Defects Foundation

The year 2002 marks the seventh annual March of Dimes Prize in Developmental Biology.

The March of Dimes Prize in Developmental Bilogy is awarded annually to investigators whose research has profoundly advanced the science that underlies our understanding of birth defects.

From the Gene to the Organism
Seymour Benzer, Division of Biology, California Institute of Technology, Pasadena, California
Sydney Brenner, The Salk Institute, La Jolla, California

Come hear a rare shared lecture by these two prominent and imaginative scientists whose last joint speaking engagement (in 1965) is still being talked about.

Seymour Benzer and Sydney Brenner were chosen to receive the 2002 March of Dimes Prize for their tremendously influential bodies of work that have helped to revolutionize and open up productive new fields of study in molecular biology and genetics. Their work has been essential to our understanding of the human organism and to the design of new treatments for human birth defects and diseases.

Dr. Benzer has made many highly original contributions to developmental biology using the fruitfly as a model organism. His work has revealed basic genetic mechanisms regulating the early steps of eye formation, the internal "biological clock," as well as the first genes that control behavior, memory, and learning. He is the subject of the 1999 book Time, Love, Memory: A Great Biologist and His Quest for the Origins of Behavior. With his latest work on the nervous system, Dr. Benzer is studying the molecular basis of pain.

In the 1950s, Dr. Brenner helped establish the existence of messenger RNA, the "working tape" copy of DNA from which cells make proteins. His pioneering work with the worm Caenorhabditis elegans in the 1960s established it as a model system that made it possible to learn how genes control development, including programmed cell death (apoptosis), and the assembly of cells into complex structures. Most recently, he has been studying vertebrate genome evolution using the Japanese puffer fish (fugu).

2:45pm-4:45pm
Topic Symposium
6501 Gene Nutrient Interaction
Chairs: Sherin Devaskar, Mattel Children's Hospital, University of California, Los Angeles, CA and William Hay, Jr., University of Colorado School of Medicine, Denver, CO
Recent exciting advances in defining the human genome have provided new opportunities in research for understanding the regulation of gene expression. One important focus of this area of science is the role of the metabolic milieu on gene expression and function during critical periods of development. This session will address the effect of nutrients and metabolic conditions on three aspects of metabolic gene regulation. William Heird will discuss how essential fatty acids regulate the expression and activity of genes and gene products that in turn are essential for regulation of fatty acid metabolism. These processes are fundamental during fetal and neonatal life when essential fatty acids are particularly important for structural development of the central nervous system and for the provision of key intermediary substrates that coordinate the development and activity of such diverse functions as vascular tone, inflammation, and nutrient metabolism. Christopher Newgard will discuss how aspects of the metabolic milieu affect pancreatic beta cell development and function, and then will explore molecular engineering approaches to modifying pancreatic beta cell/islet gene expression of genes that regulate insulin production and secretion. Barbara Kahn will discuss the molecular mechanisms involved in causing substrate-induced insulin resistance, reflecting on conditional gene knockout models of insulin resistance in adipose tissue and skeletal muscle. Together these talks will provide valuable information about mechanisms responsible for the effect of nutrients and nutrient metabolic products on key regulatory genes involved in growth and metabolism, leading to increased insight into exciting research opportunities in potential therapeutic manipulations of gene activity.

Fatty Acid Regulation of Fatty Acid Metabolism
William C. Heird, Baylor College of Medicine, Houston, TX
Molecular Mechanisms for Insulin Resistance in Obesity and Diabetes
Barbara Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Metabolic Control Mechanisms in the Pancreatic Beta Cell Studied By Genetic Engineering
Christopher B. Newgard, University of Texas Southwestern Medical Center, Dallas, TX

2:45pm-4:45pm
Platform Session
6554 Gastroenterology
Chairs: Kathleen B. Schwarz and Barry K. Wershil

2:45pm-4:45pm
Poster Symposium
6555 Gut Integrity–Necrotizing Enterocolitis
Chairs: Robert H. Lane and Philip T. Nowicki

2:45pm-4:45pm
Platform Session
6557 Mechanisms of Tissue Injury: Apoptosis
Chairs: Sandra E. Juul and Seetha Shankaran

2:45pm-4:45pm
Platform Session
6561 The Lula O. Lubchenco Symposium on Neonatal Epidemiology and Follow-Up
Chairs: Virginia Delaney-Black and T. Michael O'Shea
FEATURED SPEAKER:
Virginia Delaney-Black

2:45pm-4:45pm
Alliance Club
6580A Milk Club
Breastfeeding: Global Advances. Environmental Concerns

Achieving Population-Level Increases in Optimal Breastfeeding: Evaluation of Demonstration Projects in Developing Countries
Nadra Franklin, Academy for Educational Development, Director of Monitoring and Evaluation, LINKAGES Project
Environmental Chemicals in Human Milk
Cheston M. Berlin

4:45pm-6:30pm
Poster Session III (Author Attended)
– Gastroenterology

Tuesday, May 7, 2002

8:00am-10:00am
Topic Symposium
7001 Neonatal Cholestasis
Chairs: Frederick Suchy, Mount Sinai School of Medicine, New York, NY and William Berquist, Stanford University School of Medicine, Palo Alto, CA
This symposium will highlight the significant recent progress made in defining the etiology of neonatal cholestasis. The advances in this area over the past few years have been breathtaking. For example, the genetic basis of a number of important pediatric liver diseases has been defined, including mutations in transporters that result in several forms of progressive familial intrahepatic cholestasis. The viral etiology and genetic causes of some forms of biliary atresia have also been elucidated. Insight into liver development has also come form the identification of the gene responsible for Allagile’s Syndrome. Advances in these areas of research have been important in elucidating the pathophysiology of these disorders and have provided new insights into the molecular and cellular physiology of the normal hepatocyte.

Overview: Where We Have Come in Last Two Decades
William F. Balistreri, Children's Hospital Medical Center, Cincinnati, OH
The Pathogenesis of Biliary Atresia: The Importance of Novel Genes and Infections
Ronald J. Sokol, University of Colorado Health Science Center, The Children's Hospital, Denver, CO
Progressive Familial Intrahepatic Cholestasis
Frederick J. Suchy, Mount Sinai School of Medicine, New York
Alagille Syndrome: Insights From Identification of the Underlying Genetic Defect
David A. Piccoli, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA

Sponsored jointly with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

10:00am-11:45am
State of the Art Plenary
7201 Regenerative Medicine—From Stem Cells to Tissues
Chair: Clifford W. Bogue, Yale University School of Medicine, New Haven, CT
The potential to repair tissues and organs from stem cells has generated great excitement over the past year. Many diseases and pathological conditions, such as liver failure, spinal cord injury, Alzheimer’s disease and myocardial infarction, are now being viewed as potentially curable conditions through the use of stem cells. This session will focus on the developmental biology of stem cells and their amazing ability to give rise to many different fully-differentiated cell types. Investigators in the field of stem cell biology will discuss the potential advantages and limitations of using human embryonic stem cells, the plasticity of bone marrow-derived stem cells, and the therapeutic use of stem cells to regenerate damaged organs.

Overview
Clifford W. Bogue, Yale University School of Medicine, New Haven, CT
Human Pluripotent Stem Cells: Differentiation and Transplantation
John Gearhart, Johns Hopkins School of Medicine, Johns Hopkins Hospital, Baltimore, MD
Plasticity of Bone Marrow Derived Stem Cells
Diane Krause, Yale University School of Medicine, New Haven, CT
Potential Use of Stem Cells to Repair Infarcted Myocardium
Donald Orlic, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
Discussion

12:00pm-1:30pm
Poster Session IV (Author Attended)
– Behavioral Pediatrics
– General Pediatrics and Preventive Pediatrics

1:45pm-3:45pm
Hot Topic
7701 The Cytokine Controversy
Chair: William Keenan, St. Louis University, St Louis, MO
Recent evidence suggests that the inflammatory response of the fetus can result in brain and lung injury pre and postnatally. Are cytokines the mediators of injury or mere bystanders? What therapeutic interventions can protect the neonate? Is it already too late by birth? The speakers will present both the pros and cons of the inflammatory response and a panel discussion will attempt to summarize available information and suggest questions and potential strategies for future research.

Overview
William J. Keenan, St. Louis University, St Louis, MO
The Fetal Inflammatory Response and Preterm Brain Injury
Olaf Dammann, Harvard Medical School, Children's Hospital, Boston, MA
Cytokines and Lung Injury: The Bad
Steven R. Seidner, University of Texas Health Sciences Center, San Antonio, TX
Cytokines and Injury: The Good
Phyllis A. Dennery, Stanford University School of Medicine, Palo Alto, CA
Discussion

1:45pm-3:45pm
Hot Topic
7702 Disaster Preparedness: Beyond 9/11
Chairs: Tina L. Cheng, Johns Hopkins University School of Medicine, Baltimore, MD; Danelle Laraque, Mount Sinai School of Medicine, New York, NY; and Benard Dreyer, New York, NY
The impact of 9/11 and the public health aftermath have affected us personally and professionally. This session will address what the child health professional needs to know regarding disaster planning and preparedness. Speakers will review and provide updates on national and regional systems for emergency management and how those systems interact with local public health agencies, the pediatrician's role in the community's preparedness including what the school system, the pediatric office and the patient should be doing to prepare and respond, recognition and management of chemical and biologic agents of terrorism, and the psychological reactions to disaster and stress.

Disaster Planning and Preparedness for Child Health Professionals
George L. Foltin, New York University School of Medicine and Bellevue Hospital Center, New York, NY
Biologic Agents of Terrorism
Anne Fine, New York City Department of Health, New York, NY
Chemical Agents of Terrorism
Fred Henretig, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA
Helping Children Cope with Terrorism and Disasters
David J. Schonfeld, Yale University School of Medicine, New Haven, CT
Discussion

Copyright:
All information contained in this Website is the property of the Pediatric Academic Societies unless otherwise noted.
Duplication of any information contained herein for reasons other than personal use requires the expressed written permission of PAS
.

For comments or concerns about the website, please contact webmaster@pas-meeting.org.

Last Updated: September 27, 2006